MHS

Recent Articles

Most Americans Support Suspending Saturday Mail Delivery

Seven out of ten Americans surveyed by the New York Times/CBS News supported ending Saturday mail delivery to cut the United States Postal Service's debt. More 

The Perfect Prescription for Profits

There’s a lot to be said for going with the category killer in an investment. A merger is creating exactly that in the prescription service space. More 

Sweet Day for Shipping — Monday’s IP Market Recap

A tiny rise in the Baltic Dry Index spurs big stock gains for several shipping companies. More 

Walgreen Not Sweating Loss of Express Scripts Customers to CVS — Should It Be?

CVS says it could gobble up to 23M prescriptions that Walgreens has sold through Express Scripts if a deal isn't announced. So far, WAG is sticking to its guns. More 

Campaign to Kill Medco-Express Scripts Deal Likely Futile

It's not very likely that major pharmaceuticals will be able to prevent Express Scripts from acquiring Medco. But they do have good reason to try. More 

Sides Form on Medco-Express Scripts Deal

With the Federal Trade Commission likely to give the deal a close eye, analysts and investors sound off varying degrees of optimism and pessimism about this venture. More 

SFN, Medco Continue to Top Trading

Midday Trading Led By SFN Group (NYSE: SFN), Medco Health Solutions (NYSE: MHS), Express Scripts (NASDAQ: ESRX). More